Global Lab-on-a-chip market, by Application (Genomics, Proteomics, Diagnostics, and Drug Discovery), by Product Type (Reagents & Consumables, Software, and Instrument), by Technology (Microarrays and Microfluidics), by End User (Hospital, Diagnostic Labs, Academic and Research Institutes, Biotechnology, and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) and by Geography - Trends and Forecast to 2025

  • Published On : Nov 2017 |
  • Pages : 198 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Lab-on-a-chip Market – Miniaturized Testing, Maximized Results

Lab-on-a-chip (LoC) integrates different forms of analyses such as chemical synthesis, biochemical operations, and DNA sequencing onto a single chip. Miniaturization and optimization of these biochemical operations have resulted in cost efficiency and improved diagnostic speed. Moreover, LoC is a device that is capable of scaling single or multiple laboratory functions down to chip-format, where the size of chip ranges from millimeters to a few square centimeters. LoC is mainly the integration of electronics, fluidics, optics, and biosensors.

Increasing application of LoC in the medical field to diagnose various infections and diseases such HIV infections, chronic disease and in the field of botany is gaining traction. This is expected to drive growth of the market. Demand for LoC devices is high, owing to its features such as easy portability, automated sample handling, and re-configurability. LoC devices are suitable for point-of-care diagnosis as they provide fast and on-time diagnosis results. This is another factor expected to support growth of the market.

The microfluidic LoCs have great potential to revolutionize the biomedical field and has the potential to boost the growth of healthcare sector, as the microfluidic platforms enable the miniaturization, integration, and automation of biochemical assays, favoring the lab-on-a-chip device over traditional tests in research laboratories and pharmaceutical industry for drug discovery.

The global lab-on-a-chip market was valued at US$ 4.09 Bn in 2016 and is expected to witness a robust CAGR of 10.8% during the forecast period (2017 - 2025).

Increasing number of applications are expected to fuel the growth of Lab-On-A-Chip Market in near future

Immunoassay LoC for bacteria detection, real time PCR detection chips, DNA chip, gene chip, cellular analysis chip, and flow cytometer LoC (for HIV) are some of the applications of LoC technology in the biomedical field, as the LoC method results in less energy consumption with fast synthesis of the results, which paves the way for faster clinical translation, supporting the growth of lab-on-a-chip market. Recent advances in the field of computational simulations have made possible to synthesize the inorganic nanomaterials-based on nanomedicine in a single construct using LoC technology, which is useful for theranostic applications. This new field of medicine combines specific targeted therapy based on specific targeted diagnostic tests.

LoC devices are also used for the biomarker-based identification and early detection of oral cancer, which helps improve survival rate, and in turn favors growth of the lab-on-a-chip market. According to Center of Disease and Prevention in 2012, there were nearly 40,000 new cases of cancer of the oral cavity and pharynx diagnosed in the United States and nearly 9,000 deaths.

Furthermore, the major application of LoC systems is pathogen detection, which includes DNA-based methods with electrochemical techniques. Diseases such as Swine flu, Zika virus, and Ebola virus are major cause of deaths and risk of epidemics, which can be diagnosed early with the help of LoCs diagnostics, owing to their ability of providing diagnosis in real time to improve the disease-management landscape. Moreover, according to data published in International Journal of Bio-Science and Bio-Technology, 2016, researchers have suggested that LoC technology can be useful for finding a novel way to treat central nervous system disorders such as Parkinson’s disease and spinal cord injury with the help of extracting sufficient cerebrospinal fluid needed to perform conventional assays, which add ups one more application to the list of LoC application increasing the growth of lab-on-a-chip market in near future.  

Lab-On-A-Chip Market by Region, (US$ Billion) 2016

lab-on-chip market

SOURCE: COHERENT MARKET INSIGHTS ANALYSIS, 2017

Increasing number of diagnosis test are expected to drive the growth of Lab-on-A-Chip Market

North America accounts for the largest share in the global lab-On-A-Chip market, followed by Europe. This mainly is attributed to research and advancement in technology and wide acceptance of the lab-on-a-chip technology in the field of research and pharmaceutical company for drug discovery process and for diagnosis test. According to World Health Organization (WHO), in 2015, nearly half of the world's population were at risk of malaria and around 212 million malaria cases were reported, which in turn favors the growth of lab-on-a-chip market as malaria can be diagnosed by the lab-on-a-chip device. The lab-on-a-chip market is expected to show high growth rate in Asia Pacific region over the forecast period supported by increasing population prone to viral disease. According to Joint United Nations Programme on HIV/AIDS (UNAIDS) reports 2013, in Asia Pacific region more than 350,000 people were infected with HIV with nearly 5 million living with HIV/AIDS, which in turn is expected to propel the market growth in Asia Pacific region.

Some of the major players operating in the Lab-On-Chip market includes Takara Bio Inc., Nobel Biocare Services AG, Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc.

The Lab-On-A-Chip market is mostly influenced by its size and faster completion of clinical translations. Advancement in the technology and technique for diagnosis of pathogen based disease are expected to favor the lab-on-a-chip market. Due to the miniaturization of biochemical operations, better diagnostic speed, cost efficiency, ergonomy, sensitivity and so on can be achieved in lab-on-a-chip device. The biomedical applications of LoC in different fields like in diagnostics, cellomics, in environmental studies to control the effect of  pathogens,  to  check  the  food  quality  such  as  for  the  detection  of  various  antibiotic families in raw milk favor the growth of lab-on-a-chip market.

Lab-on-a-chip helps early detection of chronic disease, which in turn also reduces mortality rate. The theranostic application of LoC is also expected to favor the growth of LoC market as the theranostic is an emerging therapeutic paradigm, capable of diagnosis of diseases. Increasing prevalence of cancer is also a driving factor for the lab-on-a-chip market. According to data published in International Journal of Bio-Science and Bio-Technology, 2016, scientists have developed LoC devices for biomarker based identification and early detection of oral cancer.

Market Dynamics

Increasing adoption of lab-on-a-chip technology in North America is expected to boost the lab-on-a-chip market. The trend of single combined test over the numerous of test for various application favors the lab-on-a-chip market. The innovation carried out by manufacturer’s and researchers acts as a dynamic factor of lab-on-chip market. For instance, in August 2017, researchers in the engineering and chemistry departments of Brigham Young University in Utah developed a 3D printed lab-on-a-chip device to achieve true microfluidic flow.

Increasing incidence of malaria also leads to increasing demand for lab-on-a-chip PCR diagnostic method. Whereas, for the most common and chronic disease, such as Tuberculosis, the World Health Organization (WHO) has endorsed the specific molecular diagnostic technique in year 2010 to result in improvement of fast diagnosis.

Furthermore, Swine Flu, Zika Virus and Ebola virus related diseases, demand for the LoC technology as the LoC can provide diagnosis in real time.

Key features of the study:

  • This report provides an in-depth analysis of global lab-on-a-chip market provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global lab-on-a-chip market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include, Takara Bio Inc., Nobel Biocare Services AG, Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The global lab-on-a-chip market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the lab-on-a-chip market.

Detailed Segmentation:

  • Global Lab-on-a-chip Market, By Product Type:
    • Reagents and Consumables
    • Software
    • Instruments
  •  Global Lab-on-a-chip Market, By Application:
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  •  Global Lab-on-a-chip Market, By Technology:
    • Microarrays
    • Microfluidics
  • Global Lab-on-a-chip Market, By End User:
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
  • Global lab-on-a-chip market, By Geography:
    • North America
      • By Product:
  • Reagents and Consumables
  • Software
  • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
  • By Country
    • S.
    • Canada
    • Europe
  • By Product:
    • Reagents and Consumables
    • Software
    • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
  • By Country
    • K.
    • Germany
    • Italy
    • France
    • Russia
    • Spain
    • Rest of Europe
    • Asia Pacific
  • By Product:
    • Reagents and Consumables
    • Software
    • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
      • By Country
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
    • Latin America
  • By Product:
    • Reagents and Consumables
    • Software
    • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
  • By Country
    • Brazil
    • Mexico
    • Rest of Latin America
    • Middle East
  • By Product:
    • Reagents and Consumables
    • Software
    • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
  • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Product:
    • Reagents and Consumables
    • Software
    • Instruments
  • By Application
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
  • By Technology
    • Microarrays
    • Microfluidics
  • By End User
    • Hospitals
    • Diagnostic Labs
    • Academic and Research Institutes
    • Biotechnology and Pharmaceutical Companies
      • By Country
  • North Africa
  • Central Africa
  • South Africa
  • Company Profiles
  • Takara Bio Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
  • Nobel Biocare Services AG
  • Bio-Rad Laboratories Inc.
  • PerkinElmer Inc.
  • Cepheid Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Application
      • Market Snippet By Technology
      • Market Snippet By End User
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Technological Trends
    • PEST Analysis
    • Impact Analysis
  4. Global Lab-on-a-Chip Market, By Product Type, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Reagents & Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Software’s
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  5. Global Lab-on-a-Chip Market, By Application, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Genomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Proteomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Drug Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  6. Global Lab-on-a-Chip Market, By Technology, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Microarrays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Microfluidics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  7. Global Lab-on-a-Chip Market, By End User, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Diagnostic Labs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Academic & Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
    • Biotechnology & Pharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  8. Global Lab-on-a-Chip Market, By Regions, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 - 2025
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Application, 2017 – 2025 (US$ Million)
      • Market Size and Forecast, By Technology, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By End User, 2017 - 2025 (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Takra Bio Inc.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Nobel Biocare Services AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bio-Rad Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • PerkinElmer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cepheid Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 28 figures on "Lab-on-a-Chip Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.